Physician profile

Stephen D Snyder

Internal Medicine · Little Rock, AR

NPI 1053348870

$3,502.04

in general payments reported to CMS, 2019-2025

33 companies · $377 in 2025

The $377 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$1,348.18

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbvie INC. $426.74 2021-2025 Qulipta, Ubrelvy
Astrazeneca Pharmaceuticals LP $352.87 2019-2025 Farxiga, Airsupra
Abbott Laboratories $334.31 2021-2024 Freestyle Libre 3
Novartis Pharmaceuticals Corporation $262.73 2019-2025
Glaxosmithkline, LLC. $211.66 2021-2025 Arexvy, Trelegy Ellipta, Shingrix
Boehringer Ingelheim Pharmaceuticals, INC. $194.57 2019-2024 Ofev, Jardiance
Novo Nordisk INC $167.65 2019-2024 Ozempic, Rybelsus
Eisai INC. $150.32 2023-2025
Pfizer INC. $145.86 2019-2025
Dexcom, INC. $116.85 2024-2025 Dexcom G6 Transmitter
Biohaven Pharmaceuticals, INC. $109.31 2021
Lilly USA, LLC $102.14 2020-2023 Mounjaro
Allergan, INC. $97.45 2019-2020
Bayer Healthcare Pharmaceuticals INC. $96.29 2024-2025
Exact Sciences Corporation $92.45 2023-2025 Cologuard Collection Kit, The Cologuard Plus Collection Kit
Show all 33 companies
CompanyGeneral paymentsYearsTop products
Biohaven Pharmaceutical Holding Company LTD. $90.51 2022
Esperion Therapeutics, INC. $65.02 2020-2024 Nexletol
Merck Sharp & Dohme LLC $62.66 2019-2025 Capvaxive, Gardasil 9
Amgen INC. $55.14 2021-2024 Otezla, Repatha
Alnylam Pharmaceuticals INC. $53.74 2023-2024 Givlaari, Onpattro
Corcept Therapeutics $52.02 2019
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $50.99 2021-2022
Sanofi Pasteur INC. $28.50 2019-2020
Sanofi-Aventis U.S. LLC $25.50 2025
Genentech USA, INC. $25.45 2019-2020
Xeris Pharmaceuticals, INC. $23.36 2024 Gvoke Hypopen
Ultragenyx Pharmaceutical INC. $19.03 2023
Takeda Pharmaceuticals U.S.A., INC. $17.19 2019
Philips North America LLC $16.09 2022
Alexion Pharmaceuticals, INC. $15.72 2020
Shield Therapeutics INC $14.92 2024
Janssen Pharmaceuticals, INC $12.69 2019
Boston Scientific Corporation $12.31 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Stephen D Snyder

$3,502.04

in general payments reported 2019-2025

Years
2019-2025
Top company
Abbvie INC.
Context
The $377 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).

https://glasscript.com/doctor/1048052/stephen-d-snyder

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.